Metformin prevents renal interstitial fibrosis in mice with unilateral ureteral obstruction

Molecular and Cellular Endocrinology

Volumn 412, Issue , 2015, Pages 116-122

  Cavaglieri, Rita C ^a,b   Day, Robert T ^a   Feliers, Denis ^a   Abboud, Hanna E ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Adenosine monophosphate activated kinase; Fibrosis; Inflammation; Kidney; Metformin

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; METFORMIN; SCLEROPROTEIN; TRANSFORMING GROWTH FACTOR BETA; ADENYLATE KINASE; ANTIINFLAMMATORY AGENT;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; ENZYME ACTIVITY; FIBROBLAST; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; KIDNEY FIBROSIS; MACROPHAGE; MALE; MOUSE; NEPHRITIS; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; UNILATERAL URETERAL OBSTRUCTION; URETER OBSTRUCTION; ANIMAL; C57BL MOUSE; COMPLICATION; DRUG EFFECTS; FIBROSIS; IMMUNOLOGY; KIDNEY TUBULE; METABOLISM; NEPHRITIS, INTERSTITIAL; PATHOLOGY; PRECLINICAL STUDY; URETERAL OBSTRUCTION;

ADENYLATE KINASE; ANIMALS; ANTI-INFLAMMATORY AGENTS; DRUG EVALUATION, PRECLINICAL; FIBROSIS; KIDNEY TUBULES; MALE; METFORMIN; MICE, INBRED C57BL; NEPHRITIS, INTERSTITIAL; URETERAL OBSTRUCTION;

EID: 84934889666     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2015.06.006     Document Type: Article

References (29)

1. Arai M., Uchiba M., Komura H., Mizuochi Y., Harada N., Okajima K. Metformin, an antidiabetic agent, suppresses the production of tumor necrosis factor and tissue factor by inhibiting early growth response factor-1 expression in human monocytes in vitro. J. Pharmacol. Exp. Ther 2010, 334:206-213. 10.1124/jpet.109.164970.
2. Ben Sahra I., Regazzetti C., Robert G., Laurent K., Le Marchand-Brustel Y., Auberger P., et al. Metformin, independent of AMPK, induces mTOR inhibition and cell-cycle arrest through REDD1. Cancer Res 2011, 71:4366-4372. 10.1158/0008-5472.CAN-10-1769.
3. Burlá A.K., Lobato N.S., Fortes Z.B., Oigman W., Neves M.F. Cardiac fibrosis and vascular remodeling are attenuated by metformin in obese rats. Int. J. Cardiol 2013, 165:483-487. 10.1016/j.ijcard.2011.09.012.
4. Cachat F., Lange-Sperandio B., Chang A.Y., Kiley S.C., Thornhill B.A., Forbes M.S., et al. Ureteral obstruction in neonatal mice elicits segment-specific tubular cell responses leading to nephron loss. Kidney Int 2003, 63:564-575. 10.1046/j.1523-1755.2003.00775.x.
5. Chevalier R.L. Molecular and cellular pathophysiology of obstructive nephropathy. Pediatr. Nephrol 1999, 13:612-619. 10.1007/s004670050756.
6. Chevalier R.L., Forbes M.S., Thornhill B.A. Ureteral obstruction as a model of renal interstitial fibrosis and obstructive nephropathy. Kidney Int 2009, 75:1145-1152. 10.1038/ki.2009.86.
7. Chevalier R.L., Thornhill B.A., Forbes M.S., Kiley S.C. Mechanisms of renal injury and progression of renal disease in congenital obstructive nephropathy. Pediatr. Nephrol 2010, 25:687-697. 10.1007/s00467-009-1316-5.
8. Cittadini A., Napoli R., Monti M.G., Rea D., Longobardi S., Netti P.A., et al. Metformin prevents the development of chronic heart failure in the SHHF rat model. Diabetes 2012, 61:944-953. 10.2337/db11-1132.
9. Cufí S., Vazquez-Martin A., Oliveras-Ferraros C., Martin-Castillo B., Joven J., Menendez J.A. Metformin against TGFβ-induced epithelial-to-mesenchymal transition (EMT): from cancer stem cells to aging-associated fibrosis. Cell Cycle 2010, 9:4461-4468.
10. Day R.T., Cavaglieri R.C., Feliers D. Apelin retards the progression of diabetic nephropathy. Am. J. Physiol. Renal Physiol 2013, 304:F788-F800. 10.1152/ajprenal.00306.2012.
11. Eddy A.A. Molecular basis of renal fibrosis. Pediatr. Nephrol 2000, 15:290-301.
12. Eddy A.A. Progression in chronic kidney disease. Adv. Chronic Kidney Dis 2005, 12:353-365. 10.1053/j.ackd.2005.07.011.
13. El-Mir M.Y., Nogueira V., Fontaine E., Avéret N., Rigoulet M., Leverve X. Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I. J. Biol. Chem 2000, 275:223-228.
14. Grande M.T., López-Novoa J.M. Fibroblast activation and myofibroblast generation in obstructive nephropathy. Nat. Rev. Nephrol 2009, 5:319-328. 10.1038/nrneph.2009.74.
15. Guo G., Morrissey J., McCracken R., Tolley T., Klahr S. Role of TNFR1 and TNFR2 receptors in tubulointerstitial fibrosis of obstructive nephropathy. Am. J. Physiol 1999, 277:F766-F772.
16. Hirsch H.A., Iliopoulos D., Struhl K. Metformin inhibits the inflammatory response associated with cellular transformation and cancer stem cell growth. Proc. Natl. Acad. Sci. U.S.A. 2013, 110:972-977. 10.1073/pnas.1221055110.
17. Hyun B., Shin S., Lee A., Lee S., Song Y., Ha N.-J., et al. Metformin down-regulates TNF-α secretion via suppression of scavenger receptors in macrophages. Immune Netw 2013, 13:123-132. 10.4110/in.2013.13.4.123.
18. Isoda K., Young J.L., Zirlik A., MacFarlane L.A., Tsuboi N., Gerdes N., et al. Metformin inhibits proinflammatory responses and nuclear factor-kappaB in human vascular wall cells. Arterioscler. Thromb. Vasc. Biol 2006, 26:611-617. 10.1161/01.ATV.0000201938.78044.75.
19. Kalender A., Selvaraj A., Kim S.Y., Gulati P., Brûlé S., Viollet B., et al. Metformin, independent of AMPK, inhibits mTORC1 in a rag GTPase-dependent manner. Cell Metab 2010, 11:390-401. 10.1016/j.cmet.2010.03.014.
20. Kaneto H., Morrissey J., Klahr S. Increased expression of TGF-beta 1 mRNA in the obstructed kidney of rats with unilateral ureteral ligation. Kidney Int 1993, 44:313-321.
21. Kita Y., Takamura T., Misu H., Ota T., Kurita S., Takeshita Y., et al. Metformin prevents and reverses inflammation in a non-diabetic mouse model of nonalcoholic steatohepatitis. PLoS ONE 2012, 7. e43056. 10.1371/journal.pone.0043056.
22. Lee M.-J., Feliers D., Mariappan M.M., Sataranatarajan K., Mahimainathan L., Musi N., et al. A role for AMP-activated protein kinase in diabetes-induced renal hypertrophy. Am. J. Physiol. Renal Physiol 2007, 292:F617-F627. 10.1152/ajprenal.00278.2006.
23. Okada T.S. The expression of cell adhesion molecules, cadherins: markers of kidney morphogenesis. Pediatr. Nephrol 1988, 2:115-117.
24. Park C.S., Bang B.-R., Kwon H.-S., Moon K.-A., Kim T.-B., Lee K.-Y., et al. Metformin reduces airway inflammation and remodeling via activation of AMP-activated protein kinase. Biochem. Pharmacol 2012, 84:1660-1670. 10.1016/j.bcp.2012.09.025.
25. Sato M., Muragaki Y., Saika S., Roberts A.B., Ooshima A. Targeted disruption of TGF-beta1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction. J. Clin. Invest 2003, 112:1486-1494. 10.1172/JCI19270.
26. Satriano J., Sharma K., Blantz R.C., Deng A. Induction of AMPK activity corrects early pathophysiological alterations in the subtotal nephrectomy model of chronic kidney disease. Am. J. Physiol. Renal Physiol 2013, 305:F727-F733. 10.1152/ajprenal.00293.2013.
27. Viollet B., Guigas B., Sanz Garcia N., Leclerc J., Foretz M., Andreelli F. Cellular and molecular mechanisms of metformin: an overview. Clin. Sci 2012, 122:253-270. 10.1042/CS20110386.
28. Xiao H., Ma X., Feng W., Fu Y., Lu Z., Xu M., et al. Metformin attenuates cardiac fibrosis by inhibiting the TGFbeta1-Smad3 signalling pathway. Cardiovasc. Res 2010, 87:504-513. 10.1093/cvr/cvq066.
29. Zhou G., Myers R., Li Y., Chen Y., Shen X., Fenyk-Melody J., et al. Role of AMP-activated protein kinase in mechanism of metformin action. J. Clin. Invest 2001, 108:1167-1174. 10.1172/JCI13505.